Continuous and extended infusions of β-Lactam antibiotics in the pediatric population;Revisión de las infusiones continuas y prolongadas de antibióticos betalactámicos en la población pediátrica

Annals of Pharmacotherapy

Volumn 46, Issue 11, 2012, Pages 1537-1546

  Walker, Mary Covington ^a   Lam, Weng Man ^b   Manasco, Kalen B ^c  

^a WAKEMED HEALTH AND HOSPITALS   (United States)

^b Georgia Health Sciences Medical Center   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Carbapenem; Cephalosporin; Monte carlo simulation; Penicillin

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLAVULANATE POTASSIUM PLUS TICARCILLIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; MONOBACTAM; NAFCILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; PREALBUMIN; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ABDOMINAL INFECTION; ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APPENDECTOMY; BACTEREMIA; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BLOOD CULTURE; BONE AND JOINT INFECTIONS; BRONCHOSCOPY; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID CULTURE; CHRYSEOBACTERIUM MENINGOSEPTICUM; CONTINUOUS INFUSION; CREATININE CLEARANCE; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEBRILE NEUTROPENIA; FEVER; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOME CARE; HUMAN; LIVER ABSCESS; LOADING DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MENINGITIS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MONTE CARLO METHOD; NEUTROPHIL COUNT; OSTEOMYELITIS; OTITIS MEDIA; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PEDIATRICS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN INFECTION; SKIN ULCER; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHILD; COMPUTER SIMULATION; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFUSIONS, INTRAVENOUS; MONTE CARLO METHOD;

EID: 84869223143     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R216     Document Type: Review

References (26)

1. Nicolau DP, Nightingale CH, Banevicius MA, Fu Q, Quintiliani R. Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections. Antimicrob Agents Chemother 1996;40:61-4.
2. Moriyama B, Henning SA, Childs R, et al. High-dose continuous infusion b-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients. Ann Pharmacother 2010;44:929-35. doi: 10.1345/aph.1M717
3. Dalle JH, Gnansounon M, Husson MO, Ambilliotte A, Mazingue F, Nelken B. Continuous infusion of ceftazidime in the empiric treatment of febrile neutropenic children with cancer. J Pediatr Hematol Oncol 2002; 24:714-6.
4. Lodise TP, Lomaestro BM, Drusano GL. Society of Infectious Disease Pharmacists. Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Disease Pharmacists. Pharmacotherapy 2006;26:1320-32.
5. de Hoog M, Mouton JW, van den Anker JN. New dosing strategies for antibacterial agents in the neonate. Semin Fetal Neonatal Med 2005;10: 185-94. doi: 10.1016/j.siny.2004.10.004
6. David TJ, Devlin J. Continuous infusion of ceftazidime in cystic fibrosis. Lancet 1989;1:1451-5. doi: 10.1016/S0140-6736(89)90164-5
7. Rappaz I, Decosterd LA, Bille J, Pilet M, Belaz N, Roulet M. Continuous infusion of ceftazidime with a portable pump is as effective as thricea-day bolus in cystic fibrosis children. Eur J Pediatr 2000;159:919-25. doi: 10.1007/PL00008370
8. Falagas ME, Siempos II, Tsakoumis I. Cure of persistent, post-appendectomy Klebsiella pneumonia septicaemia with continuous intravenous administration of meropenem. Scand J Infect Dis 2006;38:807-10. doi: 10.1080/00365540500504125
9. Dickinson GM, Droller DG, Greenman RL, Hoffman TA. Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid. Antimicrob Agents Chemother 1981;20:481-6.doi: 10.1128/aac.20.4.481
10. Monckhof WJ, Carney J, Neilson G, et al. Continuous infusion of ticarcillin- clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 2005;25:514-22. doi: 10.1016/j.ijantimicag.2005.02.008
11. Knoderer CA, Morris JL, Cox EG. Continuous infusion of nafcillin for sternal osteomyelitis in an infant after cardiac surgery. J Pediatr Pharmacol Ther 2010;15:49-54.
12. Colding H, Anderson GE. Administration of gentamicin and ampicillin by continuous intravenous infusion to newborn infants during parenteral nutrition. Scand J Infect Dis 1982;14:61-5.
13. Colding H, Moller S, Bentzon MW. Kinetics and dose calculation of ampicillin and gentamicin given as continuous intravenous infusion during parenteral nutrition in 88 newborn infants. Dev Pharmacol Ther 1983;6:365-73.
14. Colding H, Moller S, Andersen GE. Continuous intravenous infusion of ampicillin and gentamicin during parenteral nutrition to 36 newborn infants using a dosage schedule. Acta Paediatr Scand 1984;73:203-9.
15. Hayes D Jr, Kanga JF, Anstead MI, Kuhn RJ. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure. Pediatr Pulmonol 2008;43:511-3. doi: 10.1002/ppul.20791
16. Ellis JM, Kuti JL, Nicolau DP. Use of Monte Carlo simulation to assess the pharmacodynamics of beta-lactams against Pseudomonas aeruginosa infections in children: a report from the OPTAMA program. Clin Ther 2005; 27:1820-30. doi: 10.1016/j.clinthera.2005.11.007
17. Courter JD, Kuti JL, Girotto JE, Nicolau DP. Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric population. Pediatr Blood Cancer 2009;53:379-85. doi: 10.1002/pbc.22051
18. Harrison CJ, Bratcher D. Cephalosporins: a review. Pediatr Rev 2008;29: 264-73.
19. Roos JF, Bulitta J, Lipman J, Kirkpatrick CMJ. Pharmacokinetics-pharmacodynamic rationale for cefepime dosing regimens in intensive care units. J Antimicrob Chemother 2006;58:987-93. doi: 10.1093/jac/dkl349
20. Ayalew K, Nambiar S, Yasinskaya Y, Jantausch BA. Carbapenems in pediatrics. Ther Drug Monit 2003;25:593-9.
21. Package insert. Meropenem. Wilmington, DE: AstraZeneca Pharmaceuticals LP, 2010.
22. Package insert. Ertapenem. Whitehouse Station, NJ: Merck & Co., Inc., 2011.
23. van den Anker JN, Pokorna P, Kinzig-Schippers M, et al. Meropenem pharmacokinetics in the newborn. Antimicrob Agents Chemother 2009; 53:3871-9. doi: 10.1128/aac.00351-09
24. Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009;180:802-8. doi: 10.1164/rccm.200812-1845PP
25. Mouton JW, Vinks AA. Continuous infusion of beta-lactams. Curr Opin Crit Care 2007;13:598-606. doi: 10/1097/mcc.0b013e3282e2a98f
26. Bergogne-Berezin E, Morel C, Benard Y, Berthelot G, Kafe H. Pharmacokinetic study of beta-lactam antibiotics in bronchial secretions. Scand J Infect Dis Suppl 1978;14:267-72.